0001104659-24-042348.txt : 20240402
0001104659-24-042348.hdr.sgml : 20240402
20240402120222
ACCESSION NUMBER: 0001104659-24-042348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240326
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashman Philip
CENTRAL INDEX KEY: 0001564990
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34703
FILM NUMBER: 24812877
MAIL ADDRESS:
STREET 1: 6120 WINDWARD PARKWAY, SUITE 290
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 200028718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-990-5740
MAIL ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
tm2410164-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-26
0
0001267602
ALIMERA SCIENCES INC
ALIM
0001564990
Ashman Philip
6310 TOWN SQUARE, SUITE 400
ALPHARETTA
GA
30005
0
1
0
0
President of Int'l Operations
0
Common Stock
2024-03-26
4
F
0
12103
3.83
D
118274
D
Represents shares of the Issuer's restricted common stock sold to satisfy tax obligations relating to the vesting of shares of the Issuer's restricted common stock previously awarded to the Reporting Person. Such sale was executed pursuant to the mandatory terms of the Issuer's restricted stock award agreement that are intended to permit such sale to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.88 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Philip Ashman
2024-04-02